Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Research Award - PA - Bioinformatics and Computational Biology

University of Toronto

$120,000.00

Identifying early cancer precursors in individuals at increased risk of developing lymphoma

FY 2025-26

Summary
Systemic Lupus Erythematosus (SLE) is an of autoimmune disease characterized by chronic inflammation and immune system dysfunction. People with SLE are 2 to 7 times more likely to develop lymphoma, a cancer of the immune system, than the general population. Yet the reasons for this increased risk remain poorly understood, making it difficult to identify high-risk individuals and intervene early. Research in related blood cancers has shown that pre-cancerous clones (groups of cells carrying certain genetic changes) can expand and eventually progress to leukemia. Similar processes may underlie lymphoma. Indeed, genetic changes linked to lymphoma have already been detected in "atypical B cells," a specific immune cell type that is often altered in autoimmune diseases. My research investigates whether these genetic changes also trigger shifts in how cells function, particularly in SLE patients. Using state-of-the-art single-cell technologies, I will compare atypical B cells that carry lymphoma-related genetic changes with those that do not, to identify differences in their gene activity patterns. In preliminary work, I have already confirmed that atypical B cells from SLE patients harbor mutations in genes associated with lymphoma. I will expand on this by analyzing longitudinal patient samples collected over time from individuals with and without a history of lymphoma, to identify genetic changes unique to those who progress to cancer. Finally, I will use these data to develop a machine learning (AI) tool that can predict which SLE patients are most at risk of developing lymphoma, and pinpoint which genetic changes are most informative for early detection. This study could help provide a way to identify patients who are particularly susceptible to developing lymphoma and to intervene early in these individuals.
Program
Doctoral Research Award - PA - Bioinformatics and Computational Biology
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
560954
Name
Shiba Yumika
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
Identifying early cancer precursors in individuals at increased risk of developing lymphoma
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
Doctoral Research Award - PA - Bioinformatics and Computational Biology
Keyworddelim
Autoimmune Disease; Bioinformatics; Cancer; Early Detection; Genomics; Lupus; Lymphoma; Machine Learning; Transcriptomics
Abstract
Systemic Lupus Erythematosus (SLE) is an of autoimmune disease characterized by chronic inflammation and immune system dysfunction. People with SLE are 2 to 7 times more likely to develop lymphoma, a cancer of the immune system, than the general population. Yet the reasons for this increased risk remain poorly understood, making it difficult to identify high-risk individuals and intervene early. Research in related blood cancers has shown that pre-cancerous clones (groups of cells carrying certain genetic changes) can expand and eventually progress to leukemia. Similar processes may underlie lymphoma. Indeed, genetic changes linked to lymphoma have already been detected in "atypical B cells," a specific immune cell type that is often altered in autoimmune diseases. My research investigates whether these genetic changes also trigger shifts in how cells function, particularly in SLE patients. Using state-of-the-art single-cell technologies, I will compare atypical B cells that carry lymphoma-related genetic changes with those that do not, to identify differences in their gene activity patterns. In preliminary work, I have already confirmed that atypical B cells from SLE patients harbor mutations in genes associated with lymphoma. I will expand on this by analyzing longitudinal patient samples collected over time from individuals with and without a history of lymphoma, to identify genetic changes unique to those who progress to cancer. Finally, I will use these data to develop a machine learning (AI) tool that can predict which SLE patients are most at risk of developing lymphoma, and pinpoint which genetic changes are most informative for early detection. This study could help provide a way to identify patients who are particularly susceptible to developing lymphoma and to intervene early in these individuals.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Shiba, Yumika
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~